› Forums › General Melanoma Community › Rectal melanoma stage 4
- This topic has 12 replies, 4 voices, and was last updated 11 years, 11 months ago by
arthurjedi007.
- Post
-
- May 9, 2014 at 7:33 pm
My dad just found out he has stage 4 melanoma. Doctor said the disease already spread from his rectal to liver and I saw a lot of spots in his liver that doctor can't do the surgery. I'm so worry. He has only one option for treatment is ipilimumab (yervoy.) Doctor said that medicine only 10%-15% response. If the medicine respone, he can live 6-7 years. If not, he is done.
- Replies
-
-
- May 9, 2014 at 7:52 pm
Has he been tested for BRAF mutation? If his melanoma tumors have the mutation there are other drugs that can be used to quickly reduce the tumor burden (e.g., Zelboraf) such that a treatment like ipi could be more effective (potentially).
Kevin
-
- May 9, 2014 at 7:52 pm
Has he been tested for BRAF mutation? If his melanoma tumors have the mutation there are other drugs that can be used to quickly reduce the tumor burden (e.g., Zelboraf) such that a treatment like ipi could be more effective (potentially).
Kevin
-
- May 9, 2014 at 7:52 pm
Has he been tested for BRAF mutation? If his melanoma tumors have the mutation there are other drugs that can be used to quickly reduce the tumor burden (e.g., Zelboraf) such that a treatment like ipi could be more effective (potentially).
Kevin
-
- May 9, 2014 at 8:13 pm
Since his melanoma was mucosal (rectum), has he been tested for the C-Kit mutation? Gleevec is a medicine that targets C-Kit, and C-Kit is a mutation found in mucosal melanoma. Look for JerryFromFauq's profile. He has had rectal melanoma with mets elsewhere – stage IV for many years now. He's on Gleevec and doing ok.
Please make sure your father is seeing a melanoma specialist. Yervoy is not the only option given the general info you've posted. There may be other reasons the doc suggested this course of treatment, but we try to throw all options on the table here and make sure you don't miss something obvious (like C-Kit).
-
- May 9, 2014 at 8:13 pm
Since his melanoma was mucosal (rectum), has he been tested for the C-Kit mutation? Gleevec is a medicine that targets C-Kit, and C-Kit is a mutation found in mucosal melanoma. Look for JerryFromFauq's profile. He has had rectal melanoma with mets elsewhere – stage IV for many years now. He's on Gleevec and doing ok.
Please make sure your father is seeing a melanoma specialist. Yervoy is not the only option given the general info you've posted. There may be other reasons the doc suggested this course of treatment, but we try to throw all options on the table here and make sure you don't miss something obvious (like C-Kit).
-
- May 9, 2014 at 8:13 pm
Since his melanoma was mucosal (rectum), has he been tested for the C-Kit mutation? Gleevec is a medicine that targets C-Kit, and C-Kit is a mutation found in mucosal melanoma. Look for JerryFromFauq's profile. He has had rectal melanoma with mets elsewhere – stage IV for many years now. He's on Gleevec and doing ok.
Please make sure your father is seeing a melanoma specialist. Yervoy is not the only option given the general info you've posted. There may be other reasons the doc suggested this course of treatment, but we try to throw all options on the table here and make sure you don't miss something obvious (like C-Kit).
-
- May 9, 2014 at 11:59 pm
Also if ipi doesn't work like you are rightly worried about there is also Merck's compassionate use PD1 which has info here http://www.clinicaltrials.gov/ct2/show/NCT02083484?term=NCT02083484&rank=1
-
- May 9, 2014 at 11:59 pm
Also if ipi doesn't work like you are rightly worried about there is also Merck's compassionate use PD1 which has info here http://www.clinicaltrials.gov/ct2/show/NCT02083484?term=NCT02083484&rank=1
-
- May 9, 2014 at 11:59 pm
Also if ipi doesn't work like you are rightly worried about there is also Merck's compassionate use PD1 which has info here http://www.clinicaltrials.gov/ct2/show/NCT02083484?term=NCT02083484&rank=1
-
- You must be logged in to reply to this topic.